LianBio
LIANY • Biotechnology
$0.04
▼ -0.00 (-2.50%)
Current price
EarningsLatest report: Dec 31, 2025
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$4.22M
Growth
—
Cash Flow
3/5
Trend
Mostly stable
Evidence
Positive free cash flow · 0.05Reasonable earnings multiple · 2.11Manageable debt level · 0Healthy liquidity · 1466.01Negative growth trend
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Dec 31, 2025, 12:00 AM UTCLast profile update: Sep 2, 2026, 12:17 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.04
Change-2.50%
Shares Out108.13M
Market Cap$4.22M
Enterprise Value$-561.21M
52W Range0.02 - 0.18
Beta0.07
P/E0.01
P/B0.01
P/FCF0.02
EV/EBITDA-1.80
EV/FCF-2.17
Price$0.04
Change-2.50%
Shares Out108.13M
Market Cap$4.22M
Enterprise Value$-561.21M
52W Range0.02 - 0.18
Beta0.07
P/E0.01
P/B0.01
P/FCF0.02
EV/EBITDA-1.80
EV/FCF-2.17
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio1,466.01
Quick Ratio1,466.01
Volume45.00K
Avg Volume22.71K
EPS Surprise3.74
Investment DNA
How strong this company looks for long-term investors
47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Positive free cash flow · 0.05Reasonable earnings multiple · 2.11Manageable debt level · 0Healthy liquidity · 1466.01Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 3 analyst votes · 2026-09-05
50/100
Neutral
Bullish
1
Hold
1
Bearish
1
🧾
No insider activity
No recent insider transactions available.